The Skin Cancer Center at Heidelberg University Hospital (UKHD) has been certified according to the criteria of the German Cancer Society (DKG) since 2009. It has thus been a recognized center for dermatological oncology for many years.
Due to its outstanding expertise, not only national patients from all over Germany, but also international patients with malignant skin and mucous membrane tumors as well as cancer patients with skin side effects turn to the skin tumor center. In addition, there are specialized consultation hours for immunocompromised patients.

Every year, more than 2000 patients receive guideline-based care, from prevention to the treatment of primary tumors and advanced stages of the disease, to tumor aftercare. In addition, the close connection to the National Center for Tumor Diseases (NCT) Heidelberg and the German Cancer Research Center (DKFZ) ensures access to diagnostic and therapy options based on the latest scientific findings. In the context of studies, patients at the skin tumor center are thus given access to an innovative therapy even before it is approved.